Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

July 31, 2002

Conditions

Cystic Fibrosis

Interventions

DRUG

BIIL 284 BS, low dose, pediatric patients

DRUG

BIIL 284 BS, medium dose, pediatric patients

DRUG

BIIL 284 BS, high dose, pediatric patients

DRUG

BIIL 284 BS, low dose, adult patients

DRUG

BIIL 284 BS, medium dose, adult patients

DRUG

BIIL 284 BS, high dose, adult patients

DRUG

Placebo